352 related articles for article (PubMed ID: 32268206)
21. Ethanol extract of Cyathulae Radix inhibits osteoclast differentiation and bone loss.
Shi L; Ren L; Li J; Liu X; Lu J; Jia L; Xie B; Tang S; Liu W; Zhang J
Chin J Nat Med; 2024 Mar; 22(3):212-223. PubMed ID: 38553189
[TBL] [Abstract][Full Text] [Related]
22. Anti-osteoporosis effect of Semen Cuscutae in ovariectomized mice through inhibition of bone resorption by osteoclasts.
Yang Y; Wei Q; An R; Zhang HM; Shen JY; Qin XY; Han XL; Li J; Li XW; Gao XM; He J; Mao HP
J Ethnopharmacol; 2022 Mar; 285():114834. PubMed ID: 34801609
[TBL] [Abstract][Full Text] [Related]
23. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
Chen G; Xu Q; Dai M; Liu X
Biochem Biophys Res Commun; 2019 Feb; 509(2):329-334. PubMed ID: 30579598
[TBL] [Abstract][Full Text] [Related]
24. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
[TBL] [Abstract][Full Text] [Related]
25. Ellagic acid blocks RANKL-RANK interaction and suppresses RANKL-induced osteoclastogenesis by inhibiting RANK signaling pathways.
Xu H; Chen F; Liu T; Xu J; Li J; Jiang L; Wang X; Sheng J
Chem Biol Interact; 2020 Nov; 331():109235. PubMed ID: 32971123
[TBL] [Abstract][Full Text] [Related]
26.
Kim JH; Shin H; Kim M; Kim S; Song K; Jung HS; Sohn Y
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184079
[TBL] [Abstract][Full Text] [Related]
27. Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways.
Wang T; Liu Q; Zhou L; Yuan JB; Lin X; Zeng R; Liang X; Zhao J; Xu J
Int J Mol Sci; 2015 Nov; 16(11):27470-81. PubMed ID: 26593901
[TBL] [Abstract][Full Text] [Related]
28. Madecassoside inhibits estrogen deficiency-induced osteoporosis by suppressing RANKL-induced osteoclastogenesis.
Wang Q; Yao L; Xu K; Jin H; Chen K; Wang Z; Liu Q; Cao Z; Kenny J; Liu Y; Tickner J; Xu H; Xu J
J Cell Mol Med; 2019 Jan; 23(1):380-394. PubMed ID: 30338925
[TBL] [Abstract][Full Text] [Related]
29. Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
Kim JY; Park SH; Oh HM; Kwak SC; Baek JM; Lee MS; Rho MC; Oh J
Molecules; 2014 Nov; 19(11):18465-78. PubMed ID: 25397737
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.
Zhao D; Shi Z; Warriner AH; Qiao P; Hong H; Wang Y; Feng X
PLoS One; 2014; 9(7):e102706. PubMed ID: 25032991
[TBL] [Abstract][Full Text] [Related]
31. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
[TBL] [Abstract][Full Text] [Related]
32. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
[TBL] [Abstract][Full Text] [Related]
33. Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways.
van Heerden B; Kasonga A; Kruger MC; Coetzee M
Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452958
[TBL] [Abstract][Full Text] [Related]
34. Anti-Osteoporotic Effects of Polysaccharides Isolated from Persimmon Leaves via Osteoclastogenesis Inhibition.
Hwang YH; Ha H; Kim R; Cho CW; Song YR; Hong HD; Kim T
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30011853
[TBL] [Abstract][Full Text] [Related]
35. Lactobacillus fermentation enhances the inhibitory effect of Hwangryun-haedok-tang in an ovariectomy-induced bone loss.
Shim KS; Kim T; Ha H; Lee KJ; Cho CW; Kim HS; Seo DH; Ma JY
BMC Complement Altern Med; 2013 May; 13():106. PubMed ID: 23680047
[TBL] [Abstract][Full Text] [Related]
36. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.
Liu Y; Wang C; Wang G; Sun Y; Deng Z; Chen L; Chen K; Tickner J; Kenny J; Song D; Zhang Q; Wang H; Chen Z; Zhou C; He W; Xu J
Theranostics; 2019; 9(16):4648-4662. PubMed ID: 31367247
[No Abstract] [Full Text] [Related]
37. (-)-Epicatechin 3-O-β-D-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways.
Hsiao HB; Wu JB; Lin WC
BMC Complement Altern Med; 2017 May; 17(1):245. PubMed ID: 28468652
[TBL] [Abstract][Full Text] [Related]
38. Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages.
Kim JL; Kang MK; Gong JH; Park SH; Han SY; Kang YH
Mol Nutr Food Res; 2012 Aug; 56(8):1223-33. PubMed ID: 22700286
[TBL] [Abstract][Full Text] [Related]
39. Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
Jin H; Wang Q; Chen K; Xu K; Pan H; Chu F; Ye Z; Wang Z; Tickner J; Qiu H; Wang C; Kenny J; Xu H; Wang T; Xu J
J Cell Mol Med; 2019 Dec; 23(12):8355-8368. PubMed ID: 31603626
[TBL] [Abstract][Full Text] [Related]
40. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
